FormWeb • lisinopril

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

lisinopril

lisinopril

Formulary ACE Inhibitor Formulary
Restricted Qbrelis --> restricted to pediatric patients.

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Qbrelis	SOLUTION, ORAL	1 mg/mL
Prinivil, Zestril	TABLET, ORAL	2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg, 40 mg

VIEW MORE Angiotensin-Converting Enzyme Inhibitors

Comments:

Qbrelis is formulary, not routinely stocked. If needed a liquid suspension can be prepared until the solution can be ordered. Rare use expected.

Reviewed: 28 Feb 2017 (Qbrelis)

Last updated: Mar. 21, 2026

Black Box Warning: Fetal Toxicity
Formulary, Not Routinely Stocked: Qbrelis

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.